title: Treatment with the probiotic VSL#3 as an adjunctive therapy in relapsing mild-to-moderate ulcerative colitis significantly reduces ulcerative colitis disease activity.
authors.affiliation: Stollery Children's Hospital, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Turcotte
authors.forename: Hien Q
authors.initials: HQ
authors.lastname: Huynh